Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms

American Journal of Pathology

Volumn 152, Issue 3, 1998, Pages 703-710

  Schneiderman, Jacob ^a,c   Bordin, Gerald M ^b   Adar, Raphael ^a,c   Smolinsky, Aram ^a,c   Seiffert, Dietmar ^b   Engelberg, Isaac ^a,c   Dilley, Ralph B ^b   Thinnes, Terri ^b   Loskutoff, David J ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE DISEASE; AORTA DISSECTING ANEURYSM; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN DEGRADATION;

ACUTE DISEASE; ANEURYSM, DISSECTING; AORTIC ANEURYSM, ABDOMINAL; CHRONIC DISEASE; COLLAGENASES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 9; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031937504     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hirst AE, Gore I: The etiology and pathology of aortic dissection. Aortic Dissection. Edited by Doroghazi RM, Slater EE. New York, McGraw-Hill, 1983, pp 13-54
2. DeSanctis RW, Doroghazi RM, Austen G, Buckley MJ: Aortic dissection. N Engl J Med 1987, 317:1060-1067
3. Lindsay J Jr, Hurst JW: Clinical features and prognosis in dissecting aneurysm of the aorta: a reappraisal. Circulation 1967, 35:880-888
4. Wilson SK, Hutchins GM: Aortic dissecting aneurysms: causative factors in 204 cases. Arch Pathol Lab Med 1982, 106:175-180
5. Schlatmann TJM, Becker AE: Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol 1977, 39:13-20
6. Schlatmann TJM, Becker AE: Pathogenesis of dissecting aneurysm of aorta: comparative histopathologic study of significance of medial changes. Am J Cardiol 1977, 39:21-26
7. Pyeritz RE, McKusick VA: The Marfan syndrome: diagnosis and management. N Engl J Med 1979, 300:772-777
8. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985, 44:139-266
9. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ: Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992, 89:6998-7002
10. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EKO: Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993, 13:1090-1100
11. Reilly JM, Gregorio AS, Lucore CL: Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg 1994, 19:865-872
12. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1995, 15:1444-1455
13. Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES: Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:1432-1443
14. Schneiderman J, Bordin GM, Engelberg I, Adar R, Seiffert D, Thinnes T, Bernstein EF, Dilley RB, Loskutoff DJ: Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall: a possible mechanism for aneurysm expansion. J Clin Invest 1995, 96:639-645
15. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94: 2493-2503
16. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM: Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Circulation 1995, 91:2125-2131
17. McMillan WD, Patterson BK, Keen RR, Shively VP, Cipollone M, Pearce WH: In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol 1995, 15:1139-1144
18. Shah PK, Falk EF, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstorm J, Fuster V: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Circulation 1995, 92:1565-1569
19. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC: Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995, 96:318-326
20. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995, 15: 1145-1151
21. Johnson MD, Kim HRC, Chesler L, Wu GT, Bouck N, Polverini PJ: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994, 160:194-202
22. Kamat BR, Galli SJ, Barger AC, Lainey LL, Silverman KJ: Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologie analysis. Hum Pathol 1987, 18: 1036-1042
23. Clowes AW, Clowes MM, Reidy MA, Belin D: Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 1990, 67:61-67
24. Carmeliet P, Collen D: Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis. FASEB J 1995, 9:934-938
25. Strauss BH, Robinson R, Batchlor WB, Chisholm RJ, Ravi G, Ezrin AM, Keeley FW: In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res 1996, 79:541-550
26. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW: Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 1996, 16:28-33
27. Clowes AW, Clowes, Reidy MA: Kinetics of cellular proliferation after arterial injury. III. Endothelial smooth muscle growth in chronically denuded vessels. Lab Invest 1986, 54:295-303
28. Ross R: The pathogenesis of artherosclerosis: an update. N Engl J Med 1986, 314:488-500
29. Ny T, Sawdey M, Lawrence D, Millan JL, Loskutoff DJ: Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type piasminogen activator inhibitor. Proc Natl Acad Sci USA 1986, 83:6776-6780
30. Ny T, Elgh F, Lund B: The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains. Proc Natl Acad Sci USA 1984, 81:5355-5359
31. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ: Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 1993, 142:59-70
32. Miettinnen M, Lindenmayer E, Chaubal A: Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994, 7:82-90
33. Sawa H, Lundgren C, Sobel BE, Fujii S: Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis. J Am Coll Cardiol 1994, 24:1742-1748
34. Sawdey MS, Loskutoff DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo: tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J Clin Invest 1991, 88:1346-1353
35. Sawa H, Fujii S, Sobel BE: Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis. Arterioscler Thromb 1992, 12:1507-1515
36. Slivka SR, Loskutoff DJ: Platelets stimulate endothelial cells to synthesize type 1 plasminogen activator inhibitor: evaluation of the role of transforming growth factor β. Blood 1991, 77:1013-1019
37. Reilly CF, McFall RC: Platelet-derived growth factor and transforming growth factor-β regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J Biol Chem 1991, 266:9419-9427
38. Fearns C, Sarnad F, Loskutoff DJ: Synthesis and localization of PAI-1 in the vessel wall. Vascular Control of Hemostasis. Edited by Van Hinsbergh VWM. Amsterdam, Harwood Academic Publishers, 1995, pp 207-226
39. Samad F, Yamamoto K, Pandey M, Loskutoff D: Elevated expression of transforming growth factor-β in adipose tissue from obese mice. Mol Med 1997, 3:36-47
40. Wojta J, Gallicchio M, Zoellner H, Hufnagl P, Last K, Filonzi EL, Binder BR, Hamilton JA, McGrath K: Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb Haemost 1993, 70:469-474
41. Schneiderman J, Sawdey M, Craig H, Thinnes T, Bordin G, Loskutoff DJ: Type 1 plasminogen activator inhibitor gene expression following partial hepatectomy. Am J Pathol 1993, 143:753-762
42. Podor TJ, Joshua P, Butcher M, Seiffert D, Loskutoff DJ, Gauldie J: Accumulation of type 1 plasminogen activator inhibitor and vitronectin at sites of cellular necrosis and inflammation. Ann NY Acad Sci 1992, 667:173-177
43. Tanaka H, Sukhova GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, Libby P: Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993, 88:1788-1803
44. James TW, Wagner R, White LA, Zowlak RM, Brinckerhoff CE: Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J Cell Physiol 1993, 157:426-437
45. Falk E: Why do plaques rupture? Circulation 1992, 86(Suppl 3):30-42
46. Lusby RJ, Farrell LD, Ehrenfeld WK, Stoney RJ, Wylie EJ: Carotid plaque hemorrhage. Circulation 1982, 117:1479-1487
47. Holmes DR, Liao S, Parks WC, Thompson RW: Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J Vasc Surg 1995, 21:761-772
48. Cambria RP, Brewster DC, Moncure AC, Steinberg FL, Abbott WM: Spontaneous aortic dissection in the presence of coexistent or previously repaired atherosclerotic aortic aneurysm. Ann Surg 1988, 208:619-624